Slide 1

Powerweb lunch lecture Presenting scientific posters 09 April 2015

Slide 2

What to expect? About me Your poster Audience and location Product positioning Content Design rules Posters

Slide 3

About me

Slide 4

Wow, a poster presentation! One-to-one interaction Lively informal discussion Interact with people from other fields Ample time to link you to your research

Slide 5

What does your stage look like?

Slide 6

Expand your audience

Slide 7

The brain acts a filter Total communication Perceived communication

Slide 8

Getting into their minds

Slide 9

Preparing your poster Think about 2/3 prevailing messages max ~800 words graphs are better than tables 1.5m x 2.5 m or 90 cm x 90 cm? Use proper software (e.g. Adobe InDesign, Illustrator) Set a timeline for development, review & print Handouts

Slide 10

Design start with general layout The title is large and easy to read from a distance Authors and affiliations preferably placed underneath the title

Slide 11

Design start with general layout The title is large and easy to read from a distance Authors and affiliations preferably placed underneath the title

Slide 12

Design start with general layout

Slide 13

Content Concise title Introduction preferably with bullets Intro to field Challenge Possible solution Aim

Slide 14

Content M&M and results Only essential information Leave out details Just mention standard assays/procedures Stand-alone Figures

Slide 15

Visuals say more than a thousand words

Slide 16

Slide 17

Content - Conclusion Main conclusions Contribution to the field Future directions

Slide 18

Use grids Align text and figures, horizontally and vertically Introduction CD22 is also found highly expressed on most malignant mature B cells, including follicular lymphoma (FL), marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL) [2, 3]. Moreover, CD22 is expressed in > 90% of cases of B- precursor acute lymphoblastic leukemia (ALL) [4]. CD22 is a type-I transmembrane sialoglycoprotein, whose expression is restricted to the B-cell lineage [1]. CD22 is also found highly expressed on most malignant mature B cells, including follicular lymphoma (FL), marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL) [2, 3]. Figure A. Figure shows all effects of sialoglycoprotein, whose expression is restricted to cells of the B-lineage.

Slide 19

Clever use of colors

Slide 20

A bad example

Slide 21

Slide 22

Detailed tips and advices http://colinpurrington.com/tips/poster-design http://journals.plos.org/ploscompbiol/article?id=10. 1371/journal.pcbi.0030102 http://journals.plos.org/ploscompbiol/article?id=10. 1371/journal.pcbi.0030102 http://www.bioinformaticszen.com/post/genotype- from-phenotype/ http://www.bioinformaticszen.com/post/genotype- from-phenotype/ https://jamesohanlonresearch.wordpress.com/2015/ 01/09/conference-posters-less-is-more/ https://jamesohanlonresearch.wordpress.com/2015/ 01/09/conference-posters-less-is-more/